Clinical Trials List
2025-02-07 - 2032-12-31
Phase I/II
Recruiting7
ICD-10C15.3
Malignant neoplasm of upper third of esophagus
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.0
Malignant neoplasm of cervical esophagus
-
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/12
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Chieh Yen 無
- 劉奕廷 無
- Wei-Lun Chang Digestive System Department
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Yuan Yu 無
- 唐振育 無
- 黃宣恩 無
- Yi-Ping Hung 無
- 陳宥任 無
- Yun-Cheng Hsieh 無
- 姜乃榕 無
- 翁敬堯 無
- Chueh-Chuan Yen 無
- Chien-An Liu 無
- Tien-Hua Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Mo Hou Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 陳煥武 Division of Radiology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- 張鈞弼 Division of Radiology
- Chan-Keng Yang Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Ching Chen Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsung-Jang Yeh Division of Hematology & Oncology
- Wang Yao-Kuang Digestive System Department
- Li-Tzong Chen Digestive System Department
- 王閔宏 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- Yi-Hsun Chen Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
228 participants
